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Introduction
The intestinal microbiome may play a role in the patho-
genesis of Juvenile Idiopathic Arthritis (JIA). In IBD
patients an overall decrease in microbial diversity of the
intestinal microbiota has been observed. Studies com-
paring intestinal microbiome in children with JIA and
healthy controls have not been conducted to date.
Objectives
To analyse and compare the composition and diversity
of the distal colon associated microbiome between chil-
dren with Disease-Modyfying-Anti-Rheumatic-Drug
(DMARD) naive JIA and healthy controls and to identify
specific gut bacteria associated with JIA before initiation of
a DMARD.
Methods
Total microbiome profile in stools of 8 children with
DMARD naive polyarticular JIA were analyzed by means
of IS-pro, a 16S-23S interspacer (IS) region-based profil-
ing method and compared to stools of 24 age-matched
healthy controls.
Results
Faeces of 8 (6 girls, 2 boys) children with polyarticular
JIA, all rheumatoid factor negative were investigated and
compared to 24 healthy controls. Anti-Nuclear Antibodies
were positive in 3 patients. Median age at evaluation was
11.1 years (7.3-13.1), median period from start complaints
to diagnosis was 7.1 months (4.4-13.2). Median ACR pedi
scores were: VAS physician 47 mm(32-58), VAS patient
well-being 32 mm(27-52), ESR 8 mm(2-9), active joint
count 10(7-14), limited joint count 2 (0-4), CHAQ score
1.2 (0.4-1.7).
One intra-articular steroid injection was given to each
of two patients respectively 1 and 4 months prior to
stool collection. Non Steroidal antiinflammatory Drugs
(nsaids) were used by all patients at the time of evaluation.
Median age of the healthy controls was 10.6 years
(8.4-12.9).
The median Simpsons’ diversity index within the
phylum Firmicutes in controls and JIA was 0,88, and
0,83 respectively (p < 0,012). Diversity within the phyla
Bacteriodetes and Proteobacteria did not differ between
the 2 subgroups. By constructing a Pearson-correlation
dendogram, no clustering was seen between the JIA
group and the healthy controls on species-level (figure
2), a specific JIA associated microbiotal signature could
not be identified.
Conclusion
Intestinal microbiome diversity within the phylum
Firmicutes was significantly lower between children with
DMARD naive polyarticular JIA and healthy controls.
An overall decrease in microbial diversity of the intestinal
microbiota has also been observed in IBD patients.
Whether intestinal dysbiosis plays a role in the pathogen-
esis of JIA remains subject of further studies.
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